Vimarsana
Biggest News Aggregation in the World

Page 2 - Ptom Keith Roach News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ptom Keith Roach. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ptom Keith Roach Today - Breaking & Trending Today

NICE nod for AstraZeneca's Lynparza - Vimarsana News

NICE nod for AstraZeneca's Lynparza

Therapy treats patients with specific types of ovarian, fallopian tube or primary peritoneal cancer - News - PharmaTimes

First NICE-recommended treatment for chronic heart failure - Vimarsana News

First NICE-recommended treatment for chronic heart failure

In final draft guidance, NICE has recommended dapagliflozin (Forxiga) for patients with heart failure regardless of ejection fraction.

Plunge in clinical drug trials makes Britain an urgent case for treatment - Vimarsana News

Plunge in clinical drug trials makes Britain an urgent case for treatment

With visions of the UK as a ‘life sciences superpower’ at risk, we report from Great Ormond Street hospital on what’s being done to give children access to new drugs

Enhertu accepted for use across NHS Scotland - Vimarsana News

Enhertu accepted for use across NHS Scotland

Decision will create opportunity for therapy to be used earlier in the treatment pathway - News - PharmaTimes

NHS Scotland Grants Trastuzmab Deruxtecan Approval for Use in Pretreated HER2+ Metastatic Breast Cancer - Vimarsana News

NHS Scotland Grants Trastuzmab Deruxtecan Approval for Use in Pretreated HER2+ Metastatic Breast Cancer

The Scottish Medicines Consortium has accepted fam-trastuzumab deruxtecan-nxki as a treatment option for adult patients with HER2-positive unresectable or metastatic breast cancer who have received 1 prior anti–HER2-based therapy.